Cargando…
How I treat rituximab refractory patients with WM
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305148/ https://www.ncbi.nlm.nih.gov/pubmed/30627320 http://dx.doi.org/10.18632/oncotarget.26411 |
_version_ | 1783382500356128768 |
---|---|
author | Gavriatopoulou, Maria Ntanasis-Stathopoulos, Ioannis Kastritis, Efstathios Dimopoulos, Meletios Athanasios |
author_facet | Gavriatopoulou, Maria Ntanasis-Stathopoulos, Ioannis Kastritis, Efstathios Dimopoulos, Meletios Athanasios |
author_sort | Gavriatopoulou, Maria |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6305148 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-63051482019-01-09 How I treat rituximab refractory patients with WM Gavriatopoulou, Maria Ntanasis-Stathopoulos, Ioannis Kastritis, Efstathios Dimopoulos, Meletios Athanasios Oncotarget Editorial Impact Journals LLC 2018-12-07 /pmc/articles/PMC6305148/ /pubmed/30627320 http://dx.doi.org/10.18632/oncotarget.26411 Text en Copyright: © 2018 Gavriatopoulou et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Editorial Gavriatopoulou, Maria Ntanasis-Stathopoulos, Ioannis Kastritis, Efstathios Dimopoulos, Meletios Athanasios How I treat rituximab refractory patients with WM |
title | How I treat rituximab refractory patients with WM |
title_full | How I treat rituximab refractory patients with WM |
title_fullStr | How I treat rituximab refractory patients with WM |
title_full_unstemmed | How I treat rituximab refractory patients with WM |
title_short | How I treat rituximab refractory patients with WM |
title_sort | how i treat rituximab refractory patients with wm |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305148/ https://www.ncbi.nlm.nih.gov/pubmed/30627320 http://dx.doi.org/10.18632/oncotarget.26411 |
work_keys_str_mv | AT gavriatopouloumaria howitreatrituximabrefractorypatientswithwm AT ntanasisstathopoulosioannis howitreatrituximabrefractorypatientswithwm AT kastritisefstathios howitreatrituximabrefractorypatientswithwm AT dimopoulosmeletiosathanasios howitreatrituximabrefractorypatientswithwm |